/THCT
THCT Stock - THC Therapeutics, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
35
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.SELL
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for THCT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta7.53
52W High$0.02
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-1,393 | $-12,334 | $-16,370 | $-20,114 | $-25,558 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-493,912 | $-1,746,028 | $-939,977 | $-1,318,410 | $-26,689,910 |
| Net Income | $-387,036 | $-1,518,929 | $-1,885,445 | $-1,925,179 | $-23,610,650 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.01 | $-0.05 | $-0.08 | $-0.15 | $-1.77 |
Company Overview
THC Therapeutics, Inc. operates in the wellness industry. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
THCTBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q4 2024
EPS Surprise History
Q4 22
No data
Q4 22
No data
Q1 24
No data
Q1 24
No data
Q1 24
No data
Q3 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 11, 2025 | — | — | — | — |
Q3 2025 | Aug 11, 2025 | — | — | — | — |
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q1 2025 | Mar 19, 2025 | — | — | — | — |
Q4 2024 | Nov 13, 2024 | — | $0.00 | — | — |
Q3 2024 | Sep 4, 2024 | — | $-0.02 | — | — |
Q3 2024 | Aug 9, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 26, 2024 | — | $-0.00 | — | — |
Q1 2024 | Jan 9, 2024 | — | $0.00 | — | — |
Q1 2024 | Jan 8, 2024 | — | $0.05 | — | — |
Q4 2022 | Dec 22, 2022 | — | $-0.13 | — | — |
Q4 2022 | Nov 23, 2022 | — | $0.04 | — | — |
Q2 2022 | Jun 16, 2022 | — | $-0.04 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.02 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.04 | — | — |
Q2 2021 | Jun 21, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 26, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 17, 2020 | — | $-0.00 | — | — |
Q4 2020 | Nov 4, 2020 | — | $0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about THCT
What is THCT's current stock price?
THC Therapeutics, Inc. (THCT) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for THCT?
No analyst price targets are currently available for this stock.
What sector is THC Therapeutics, Inc. in?
THC Therapeutics, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is THCT's market cap?
THC Therapeutics, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does THCT pay dividends?
No, THC Therapeutics, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCVHIF
Ventura Cannabis & Wellness Corporation
$0.00
Mkt Cap: $0.0B
CYPS
Cyclo3pss Corporation
$0.00
Mkt Cap: $0.0B
EMGE
Emergent Health Corp
$0.00
Mkt Cap: $0.0B
NLVVF
New Leaf Ventures Inc
$0.00
Mkt Cap: $0.0B
NMRD
Nemaura Medical Inc.
$0.00
Mkt Cap: $0.0B
NMXS
Net Medical Xpress Solutions, Inc.
$0.00
Mkt Cap: $0.0B
QMDT
Quick-Med Technologies, Inc.
$0.00
Mkt Cap: $0.0B
REMI
Remedent, Inc.
$0.00
Mkt Cap: $0.0B
TNGNQ
Tengion, Inc.
$0.00
Mkt Cap: $0.0B
UPH
UpHealth, Inc.
$0.30
Mkt Cap: $0.0B
Explore stocks similar to THCT for comparison